Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer

NCT00165464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer
GE Junction Cancer

Interventions

DRUG: Taxotere
DRUG: Cisplatin
DRUG: Irinotecan

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]